|Articles|June 22, 2016
CenterWatch Joins WIRB-Copernicus Group
WIRB-Copernicus Group has acquired clinical trials information provider CenterWatch, and added its founder and owner, Kenneth A. Getz, to WCG’s board of directors.
Advertisement
WIRB-Copernicus Group has acquired clinical trials information provider CenterWatch, and added its founder and owner, Kenneth A. Getz, to WCG’s board of directors. According to WCG, the acquisition will facilitate an increase in sharing of knowledge and communication among key stakeholders in clinical research.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
Operational Strategies That Strengthened the NIMBLE Trial DesignSeptember 16th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Merck Reports Strong Phase II Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer
2
Phase IV Trial Shows Daybue Demonstrates Real-World Behavioral Improvements in Rett Syndrome
3
Capvaxive Demonstrates Robust Immune Responses in Children, Adolescents at Increased Risk of Pneumococcal Disease
4
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
